UK Leeds Peers C: Difference between revisions

From Bioblast
No edit summary
No edit summary
Line 10: Line 10:
|country=United Kingdom
|country=United Kingdom
|MiPNetLab=Boyle JP, Peers C
|MiPNetLab=Boyle JP, Peers C
|info=[http://www.oroboros.at/index.php?ioc46-schroecken IOC46], [http://www.oroboros.at/index.php?IOC66 IOC66], [http://oroboros.at/index.php?id=ioc68 IOC68]
|info=[http://oroboros.at/index.php?id=ioc68 IOC68], [http://www.oroboros.at/index.php?IOC66 IOC66], [http://www.oroboros.at/index.php?ioc46-schroecken IOC46]
|Field_of_interest=Alzheimer disease
|Field_of_interest=Alzheimer disease
|Info=[http://www.oroboros.at/index.php?id=1271 UK_Leeds_PeersC]
|Info=[http://www.oroboros.at/index.php?id=1271 UK_Leeds_PeersC]
}}
}}

Revision as of 16:49, 3 May 2012

Cookies help us deliver our services. By using our services, you agree to our use of cookies.